Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides

被引:347
作者
Straus, Suzana K.
Hancock, Robert E. W.
机构
[1] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada
[2] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2006年 / 1758卷 / 09期
基金
加拿大自然科学与工程研究理事会;
关键词
Daptomycin; lipopeptide; cationic peptide; Gram-positive pathogen; mechanism of action;
D O I
10.1016/j.bbamem.2006.02.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the steady rise in the number of antibiotic-resistant Gram-positive pathogens, it has become increasingly important to find new antibacterial agents which are highly active and have novel and diversified mechanisms of action. Two classes will be discussed here: the cationic antimicrobial peptides, which are amphiphilic in nature, targeting membranes and increasing their permeability; and lipopeptides, which consist of linear or cyclic peptides with an N-terminus that is acylated with a fatty acid side chain. One member of the cyclic lipopeptide family, the anionic molecule daptomycin, has been extensively studied and is the major focus of this review. Models will be presented on its mode of action and comparisons will be made to the known modes of action of cationic antimicrobial peptides and other lipopeptides. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1215 / 1223
页数:9
相关论文
共 98 条
[1]   Novel antibacterial agents for the treatment of serious Gram-positive infections [J].
Abbanat, D ;
Macielag, M ;
Bush, K .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) :379-399
[2]   Daptomycin, a new drug class for the treatment of gram-positive infections [J].
Alder, JD .
DRUGS OF TODAY, 2005, 41 (02) :81-90
[3]   INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS IN GRAM-POSITIVE BACTERIA BY LY146032 [J].
ALLEN, NE ;
HOBBS, JN ;
ALBORN, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1093-1099
[4]   THE EFFECT OF CULTURAL CONDITIONS ON THE ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI AND STREPTOCOCCI [J].
ANDREW, JH ;
WALE, MCJ ;
WALE, LJ ;
GREENWOOD, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (02) :213-221
[5]   The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].
Arbeit, RD ;
Maki, D ;
Tally, FP ;
Campanaro, E ;
Eisenstein, BI .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681
[6]   A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid [J].
Avrahami, D ;
Shai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12277-12285
[7]   Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: A plausible mode of action [J].
Avrahami, D ;
Shai, Y .
BIOCHEMISTRY, 2003, 42 (50) :14946-14956
[8]   NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin [J].
Ball, LJ ;
Goult, CM ;
Donarski, JA ;
Micklefield, J ;
Ramesh, V .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (13) :1872-1878
[9]   In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922
[10]   LY146032 COMPARED WITH PENICILLIN-G IN EXPERIMENTAL AORTIC-VALVE ENDOCARDITIS CAUSED BY GROUP-G STREPTOCOCCI [J].
BAYER, AS ;
YIH, J ;
HIRANO, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (01) :141-143